Form 4: United Therapeutics EVP Paul Mahon Reports Share Tracking Award Exercise and Stock Disposal
SEC Form 4
Paul Mahon, EVP & General Counsel of United Therapeutics, reports exercising share tracking awards and disposing of common stock on June 20, 2024.
Summary
- On June 20, 2024, Paul A. Mahon, EVP & General Counsel of United Therapeutics Corp, exercised share tracking awards for 25,000 shares at a price of $163.3.
- Concurrently, Mahon disposed of 25,000 shares of common stock at $163.3 and 25,000 shares of common stock at $308.98.
- Following these transactions, Mahon directly owns 36,710 shares of United Therapeutics common stock and 91,250 share tracking awards.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing insider transactions, which is neutral in sentiment.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, providing transparency to the market regarding the actions of company executives.
Stakeholder Impact
- The transactions may provide insights to stakeholders regarding management's perspective on the company's value.
Key Dates
| Date | Description |
|---|---|
| 03/13/2016 | Date exercisable for Share Tracking Award |
| 03/13/2025 | Expiration date for Share Tracking Award |
| 06/20/2024 | Date of transaction (exercise of share tracking awards and stock disposal) |
| 06/24/2024 | Date of signature for the report |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.